Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cross-Presenting XCR1+ Dendritic Cells as Targets for Cancer Immunotherapy
Katherine M. Audsley, Alison M. McDonnell, Jason Waithman
Cells (2020) Vol. 9, Iss. 3, pp. 565-565
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Functional states of myeloid cells in cancer
Lilian van Vlerken-Ysla, Yulia Y. Tyurina, Valerian E. Kagan, et al.
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 490-504
Open Access | Times Cited: 119
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
Raquel S. Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 94
Recent developments in application of single-cell RNA sequencing in the tumour immune microenvironment and cancer therapy
Peiheng Li, Xiangyu Kong, Yazhou He, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 94
Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer
Alessio Ugolini, Vladimir A. Tyurin, Yulia Y. Tyurina, et al.
JCI Insight (2020) Vol. 5, Iss. 15
Open Access | Times Cited: 109
Dysfunction of dendritic cells in tumor microenvironment and immunotherapy
Jie Chen, Yu-Hang Duan, Junye Che, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 1047-1070
Open Access | Times Cited: 12
Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer
Libo Liu, Longhao Xu, Daqin Wu, et al.
EBioMedicine (2024) Vol. 104, pp. 105152-105152
Open Access | Times Cited: 9
Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials
Zubair Hussain, Yueteng Zhang, Lu Qiu, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications
Annalisa Del Prete, Francesca Sozio, Ilaria Barbazza, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3930-3930
Open Access | Times Cited: 53
IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma
Sheridan L. Swan, Nalini Mehta, Ekaterina Ilich, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Recent Progress in Dendritic Cell-Based Cancer Immunotherapy
Kazuhiko Matsuo, Osamu Yoshie, Kosuke Kitahata, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2495-2495
Open Access | Times Cited: 39
Combinations of Radiotherapy with Vaccination and Immune Checkpoint Inhibition Differently Affect Primary and Abscopal Tumor Growth and the Tumor Microenvironment
Michael Rückert, Lisa Deloch, Benjamin Frey, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 714-714
Open Access | Times Cited: 37
PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis
Thaís G. Moreira, Davide Mangani, Laura M. Cox, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Role of chemokines in hepatocellular carcinoma (Review)
Dongdong Xue, Ya Zheng, Junye Wen, et al.
Oncology Reports (2020) Vol. 45, Iss. 3, pp. 809-823
Open Access | Times Cited: 32
Trial watch: intratumoral immunotherapy
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 25
Tumor vaccines: Toward multidimensional anti-tumor therapies
Yuanfang Tan, H. S. Chen, Xi Gou, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 11
GIMAP1 interacts with TMX1 to improve lung adenocarcinoma prognosis by influencing tumor immune microenvironment
Pinglang Ruan, Jiani Li, Khalid A. Abdelhalim, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167661-167661
Closed Access
Stimulation of regulatory dendritic cells suppresses cytotoxic T cell function and alleviates DEN-induced liver injury, fibrosis and hepatocellular carcinoma
Jun‐Jie Wang, Ping Gong, Qingqing Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Intradermal Injection of a Protein Alone Without Additional Adjuvants Using a Needle-Free Pyro-Drive Jet Injector Induces Potent CD8+ T Cell-Mediated Antitumor Immunity
Jukito Sonoda, Izuru Mizoguchi, Natsuki Yamaguchi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4442-4442
Open Access
Vaccine-Induced CD8+ T Cell Responses in Children: A Review of Age-Specific Molecular Determinants Contributing to Antigen Cross-Presentation
Elisabeth M. S. Beijnen, Simon D. van Haren
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 21
Genetic variation analyses indicate conserved SARS‐CoV‐2–host interaction and varied genetic adaptation in immune response factors in modern human evolution
Ji‐Won Lee, In‐Hee Lee, Takanori Sato, et al.
Development Growth & Differentiation (2021) Vol. 63, Iss. 3, pp. 219-227
Open Access | Times Cited: 20
Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma
Chunmei Zhu, Qiuji Wu, Ningning Yang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 9
Conventional Type 1 Dendritic Cells in Intestinal Immune Homeostasis
Izumi Sasaki, Takashi Kato, Hiroaki Hemmi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Research Progress of Dendritic Cell Surface Receptors and Targeting
Chunyu Tong, Yimin Liang, Xianle Han, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1673-1673
Open Access | Times Cited: 5
Host genetic determinants of COVID‐19 susceptibility and severity: A systematic review and meta‐analysis
Setegn Eshetie, Pastor Jullian, Beben Benyamin, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Open Access | Times Cited: 5
XCR1: A promising prognostic marker that pinpoints targeted and immune-based therapy in hepatocellular carcinoma
Wei Wu, Zhen Bao, Kai Zhu, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31968-e31968
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top